检索范围:
排序: 展示方式:
Biodegradable polymethacrylic acid grafted psyllium for controlled drug delivery systems
Ranvijay KUMAR, Kaushlendra SHARMA
《化学科学与工程前沿(英文)》 2013年 第7卷 第1期 页码 116-122 doi: 10.1007/s11705-013-1310-0
关键词: psyllium acetyl salicylic acid in-vitro drug release swelling biodegradation
Semi-solid materials for controlled release drug formulation: current status and future prospects
Michelle TRAN,Chun WANG
《化学科学与工程前沿(英文)》 2014年 第8卷 第2期 页码 225-232 doi: 10.1007/s11705-014-1429-7
关键词: controlled release drug delivery semi-solids polymer excipient
Controlled drug release of 5-amino salicylic acid by poly(2-hydroxyethylmethacrylate) grafted agar
G. Usha RANI,Kartick Prasad DEY,Srijita BHARTI,Sumit MISHRA
《化学科学与工程前沿(英文)》 2014年 第8卷 第4期 页码 465-470 doi: 10.1007/s11705-014-1452-8
关键词: agar controlled drug release 5-Amino salicylic acid poly(2-hydroxyethylmethacrylate) grafted agar
Xiaojing ZHANG, Weixin ZHANG, Zeheng YANG, Zhao ZHANG
《化学科学与工程前沿(英文)》 2012年 第6卷 第3期 页码 246-252 doi: 10.1007/s11705-012-1299-9
Vaibhav Mundra, Ram I. Mahato
《化学科学与工程前沿(英文)》 2014年 第8卷 第4期 页码 387-404 doi: 10.1007/s11705-014-1457-3
关键词: nanocarrier cellular uptake endosomal release nucleic acid drug
Juichen YANG,Hong CHEN,Yuan YUAN,Debanjan SARKAR,Jie ZHENG
《化学科学与工程前沿(英文)》 2014年 第8卷 第4期 页码 498-510 doi: 10.1007/s11705-014-1451-9
关键词: phase structure degradation polyurethanes controlled release drug delivery
A novel cataplasma matrix of traditional Chinese medicine
Jing TIAN, Xiaolei ZHANG, Xueqin ZHOU,
《化学科学与工程前沿(英文)》 2010年 第4卷 第1期 页码 91-95 doi: 10.1007/s11705-009-0304-4
null
《医学前沿(英文)》 2016年 第10卷 第4期 页码 517-521 doi: 10.1007/s11684-016-0480-9
This study aimed to compare the antimicrobial activities of topical agents against Propionibacterium acnes isolated from patients admitted to a hospital in Shanghai, China. The minimal inhibitory concentrations of the cultured P. acnes were determined in accordance with the Clinical and Laboratory Standards Institute. Susceptibilities to clindamycin and erythromycin were compared in terms of gender, age, disease duration, previous treatment, and disease severity. A total of 69 P. acnes strains were isolated from 98 patients (70.41%). The susceptibility to triple antibiotic ointment (neomycin/bacitracin/polymyxin B) and bacitracin was 100%. The susceptibility to fusidic acid was 92.7%. The resistance rates to neomycin sulfate, erythromycin, and clindamycin were 11.7%, 49.3%, and 33.4%, respectively. The high resistance rate to clindamycin and erythromycin was significantly affected by gender, previous treatment, and disease severity rather than by age and disease duration. Topical antibiotics should not be used separately for long-term therapy to avoid multiresistance. The use of topical antibiotics should be determined by clinicians on the basis of clinical conditions.
关键词: antimicrobial susceptibility/resistance Propionibacterium acnes topical antibiotics in vitro study
Taking advantage of drug resistance, a new approach in the war on cancer
null
《医学前沿(英文)》 2018年 第12卷 第4期 页码 490-495 doi: 10.1007/s11684-018-0647-7
Identification of the driver mutations in cancer has resulted in the development of a new category of molecularly targeted anti-cancer drugs. However, as was the case with conventional chemotherapies, the effectiveness of these drugs is limited by the emergence of drug-resistant variants. While most cancer therapies are given in combinations that are designed to avoid drug resistance, we discuss here therapeutic approaches that take advantage of the changes in cancer cells that arise upon development of drug resistance. This approach is based on notion that drug resistance comes at a fitness cost to the cancer cell that can be exploited for therapeutic benefit. We discuss the development of sequential drug therapies in which the first therapy is not given with curative intent, but to induce a major new sensitivity that can be targeted with a second drug that selectively targets the acquired vulnerability. This concept of collateral sensitivity has hitherto not been used on a large scale in the clinic and holds great promise for future cancer therapy.
关键词: cancer drug resistance genetic screens senescence targeted therapy
Kaifeng RAO, Na LI, Mei MA, Zijian WANG
《环境科学与工程前沿(英文)》 2014年 第8卷 第1期 页码 69-78 doi: 10.1007/s11783-013-0502-7
关键词: waste water in vitro recombinant yeast assay ethoxyresorufin-O-deethylase (EROD) receptor endocrine
null
《医学前沿(英文)》 2016年 第10卷 第1期 页码 41-51 doi: 10.1007/s11684-016-0429-z
Midline2 (MID2) is an ubiquitin-conjugating E2 enzyme linked to tumor progression and a novel interacting partner of breast cancer 1, early-onset (BRCA1). However, the role of MID2 in breast cancer remains unknown. This study investigated the expression, prognostic value, and role of MID2 in breast cancer. The expression of MID2 mRNA and protein was significantly upregulated in breast cancer tissue and established cell lines compared with that in normal breast epithelial cells and paired adjacent non-tumor tissue (P<0.001). Immunohistochemical analysis demonstrated that MID2 was overexpressed in 272 of 284 (95.8%) paraffin-embedded, archived breast cancer tissue. Moreover, MID2 expression increased with advanced clinical stage (P<0.001). High MID2 expression was significantly associated with advanced clinical stages and T, N, and M staging (all P<0.05). Univariate and multivariate analyses indicated that high MID2 expression was an independent prognostic factor for poor overall survival in the entire cohort (93.73 vs. 172.1 months; P<0.001, log-rank test) and in subgroups with stages Tis+ I+ II and III+ IV. Furthermore, 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide colony formation, and anchorage-independent growth ability assays were conducted. Results showed that siRNA silencing of MID2 expression significantly reduced MCF-7 and MDA-MB-231 cell proliferation in vitro and blocked the growth of MDA-MB-231 cell xenograft tumors in vivo (P<0.05). This study indicated that MID2 may be a novel prognostic marker and interventional target in breast cancer.
关键词: breast cancer MID2 proliferation overall survival xenograft
IN VITRO ACTIVITY OF EXTRACTS OF FIVE MEDICINAL PLANT SPECIES ON PLANT PATHOGENIC FUNGI
《农业科学与工程前沿(英文)》 2021年 第8卷 第4期 页码 635-644 doi: 10.15302/J-FASE -2020343
The antifungal effectiveness of extracts of five medicinal plant species was determined. The inhibitory activity of extracts of Eucalyptus tereticornis, Xanthium sibiricum, Artemisia argyi, Tupistra chinensis and Pyrola calliantha were evaluated against the mycelial growth of the plant pathogenic fungi Aspergillus niger, Botrytis cinerea, Penicillium digitatum, P. expansum, P. italicumand Rhizopus stolonifer. All plant extracts were prepared at 60°C using solvents (either water, 50% ethanol (v/v), 95% ethanol (v/v), ethyl acetate or petroleum ether). Fungicidal effects of all plants tested were confirmed. Different extracts from the same plant species gave different degrees of inhibition. All aqueous extracts had weak or no activity on all fungi tested. Ethyl acetate and 95% ethanol extracts from T. chinensis rhizomes gave greater inhibition and a broader spectrum inhibition than the other extracts. T. chinensis may have potential as a new natural fungicide and may be used for the preservation of agricultural and forestry products such as fruits and vegetables.
关键词: Botrytis cinerea / food preservation / plant diseases / plant pathogenic fungi / Tupistra chinensis
Protein microspheres for pulmonary drug delivery
Yongda SUN,
《化学科学与工程前沿(英文)》 2010年 第4卷 第1期 页码 82-86 doi: 10.1007/s11705-009-0307-1
关键词: advanced engineering improved pressure aqueous technique
Study on the NOx release rule along the boiler during pulverized coal combustion
JIN Jing, ZHANG Zhongxiao, LI Ruiyang
《能源前沿(英文)》 2007年 第1卷 第1期 页码 91-95 doi: 10.1007/s11708-007-0009-7
Capacity estimation and preliminary strategy for reducing the release of dioxins in China
YU Gang, ZHANG Qing, HUANG Jun, CAI Zhenxiao, SUI Qian
《环境科学与工程前沿(英文)》 2007年 第1卷 第1期 页码 13-17 doi: 10.1007/s11783-007-0002-8
标题 作者 时间 类型 操作
Biodegradable polymethacrylic acid grafted psyllium for controlled drug delivery systems
Ranvijay KUMAR, Kaushlendra SHARMA
期刊论文
Semi-solid materials for controlled release drug formulation: current status and future prospects
Michelle TRAN,Chun WANG
期刊论文
Controlled drug release of 5-amino salicylic acid by poly(2-hydroxyethylmethacrylate) grafted agar
G. Usha RANI,Kartick Prasad DEY,Srijita BHARTI,Sumit MISHRA
期刊论文
Nanostructured hollow spheres of hydroxyapatite: preparation and potential application in drug delivery
Xiaojing ZHANG, Weixin ZHANG, Zeheng YANG, Zhao ZHANG
期刊论文
Design of nanocarriers for efficient cellular uptake and endosomal release of small molecule and nucleic
Vaibhav Mundra, Ram I. Mahato
期刊论文
Synthesis and characterization of biocompatible polyurethanes for controlled release of hydrophobic and
Juichen YANG,Hong CHEN,Yuan YUAN,Debanjan SARKAR,Jie ZHENG
期刊论文
A novel cataplasma matrix of traditional Chinese medicine
Jing TIAN, Xiaolei ZHANG, Xueqin ZHOU,
期刊论文
Antimicrobial activity of topical agents against Propionibacterium acnes: an in vitro study of clinical
null
期刊论文
In vitro agonistic and antagonistic endocrine disrupting effects of organic extracts from waste water
Kaifeng RAO, Na LI, Mei MA, Zijian WANG
期刊论文
and a prognostic indicator in human breast cancer and promotes breast cancer cell proliferation in vitro
null
期刊论文
Study on the NOx release rule along the boiler during pulverized coal combustion
JIN Jing, ZHANG Zhongxiao, LI Ruiyang
期刊论文